Stay updated on HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Sign up to get notified when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.

Latest updates to the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows an updated revision label: v3.4.2 replaces the previous v3.4.1.SummaryDifference0.1%

- Check20 days agoChange DetectedA minor revision tag was updated from v3.4.0 to v3.4.1 on the page, with no changes to study content or eligibility details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedUI/content updates include showing the glossary toggle and updating header/footer/version text: added 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', while the corresponding lowercased items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedRevision on the page footer updated from v3.3.3 to v3.3.4, a minor metadata/version change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section added with Washington as a study site, the previous 'Washington Locations' entry was removed, and the page footer shows Revision: v3.3.3.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision history updated to v3.3.2 (replacing v3.2.0).SummaryDifference0.1%

Stay in the know with updates to HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HSV529 Vaccine in HSV-2 Seropositive Adults Clinical Trial page.